4 completed, 2 terminated, 1 active not recruiting. 7 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Terminated 2, Active not recruiting 1 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow pridopidine: new trials by email Literature Review of pridopidine trials Research Report on pridopidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEALEY ALS Platform Trial - Regimen D Pridopidine Pridopidine, Matching Placebo - Amyotrophic Lateral Sclerosis | Phase 2 / Phase 3 | Completed | Merit E. Cudkowicz, MD | 163 | 2020-12-18 | 2023-08-23 |
| HEALEY ALS Platform Trial - Master Protocol Zilucoplan, Verdiperstat, CNM-Au8 - Amyotrophic Lateral Sclerosis | Phase 2 / Phase 3 | Active not recruiting | Merit E. Cudkowicz, MD | 1500 | 2020-06-14 | 2026-07-21 |
| A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease Pridopidine, Placebo - Parkinson Disease | Phase 2 | Terminated | Prilenia | 23 | 2019-05-22 | 2022-07-01 |
| A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease Pridopidine - Huntington's Disease | Phase 2 | Terminated | Prilenia | 248 | 2015-09-24 | 2021-09-17 |
| A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease Pridopidine, Placebo - Huntington's Disease | Phase 2 | Completed | Prilenia | 408 | 2014-02-28 | 2021-07-19 |
| Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease pridopidine - Huntington Disease | Phase 2 | Completed | Prilenia | 134 | 2011-03-24 | 2022-02-09 |
| A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease ACR16, Placebo - Huntington Disease | Phase 2 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 227 | 2008-10-24 | 2023-08-31 |
Huntington Disease (4) · Amyotrophic Lateral Sclerosis (2) · Dyskinesias (1) · Parkinson Disease (1)
Prilenia (4) · Merit E. Cudkowicz, MD (2) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
United States (6) · Canada (3) · Australia (2) · Austria (2) · France (2) · Germany (2) · Italy (2) · Netherlands (2) · Poland (2) · Russia (2) · United Kingdom (2) · Denmark (1)
Merit Cudkowicz, MD (2) · Yael Cohen (1)
PMID 36811812, PMID 40067755, PMID 28826192, PMID 30563778, PMID 30572891, PMID 30776019, PMID 31356217, PMID 39960672, PMID 40067754, PMID 40067821, PMID 41406304
2015 (1)